Literature DB >> 10364374

Deletion mutagenesis within the dimerization initiation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins.

C Liang1, L Rong, E Cherry, L Kleiman, M Laughrea, M A Wainberg.   

Abstract

Previous work has shown that deletions of genomic segments at nucleotide (nt) positions +238 to +253, i.e., construct BH10-LD3, or nt positions +261 to +274, i.e., construct BH10-LD4, within the human immunodeficiency virus type 1 (HIV-1) dimerization initiation site (DIS) destroyed DIS secondary structure and dramatically reduced viral replication capacity. Surprisingly, two point mutations located within the viral peptide 2 (p2) and nucleocapsid (NC) protein termed MP2 and MNC, respectively, were able to compensate for this defect. Since the MP2 mutation involves an amino acid substitution near the cleavage site between p2 and NC, we investigated the effects of the above-mentioned deletions on the processing of Gag proteins. Immunoprecipitation assays performed with monoclonal antibodies against viral capsid (CA) (p24) protein showed that p2 was cleaved from CA with less efficiency in viruses that contained the LD3 and LD4 deletions than in wild-type viruses. The presence of the two compensatory mutations, MP2 and MNC, increased the efficiency of the cleavage of p2 from CA, but neither mutation alone had this effect or was sufficient to compensate for the observed impairment in infectiousness. A virus that contained both of the above-mentioned deletions within the DIS was also impaired in regard to processing and infectiousness, and it could likewise be compensated by the MP2 and MNC point mutations. These results suggest that the DIS region of HIV-1 RNA plays an important role in the processing of Gag proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364374      PMCID: PMC112683     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Role of the DIS hairpin in replication of human immunodeficiency virus type 1.

Authors:  B Berkhout; J L van Wamel
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication.

Authors:  C Liang; L Rong; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.

Authors:  I Gross; H Hohenberg; H G Kräusslich
Journal:  Eur J Biochem       Date:  1997-10-15

5.  Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo.

Authors:  J I Sakuragi; A T Panganiban
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Mutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization.

Authors:  M Laughrea; L Jetté; J Mak; L Kleiman; C Liang; M A Wainberg
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  A dual role of the putative RNA dimerization initiation site of human immunodeficiency virus type 1 in genomic RNA packaging and proviral DNA synthesis.

Authors:  J C Paillart; L Berthoux; M Ottmann; J L Darlix; R Marquet; B Ehresmann; C Ehresmann
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Mode of dimerization of HIV-1 genomic RNA.

Authors:  G Awang; D Sen
Journal:  Biochemistry       Date:  1993-10-26       Impact factor: 3.162

9.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

Authors:  A Lever; H Gottlinger; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation.

Authors:  J L Clever; T G Parslow
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

View more
  23 in total

1.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging.

Authors:  N Shen; L Jetté; C Liang; M A Wainberg; M Laughrea
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Partial restoration of replication of simian immunodeficiency virus by point mutations in either the dimerization initiation site (DIS) or Gag region after deletion mutagenesis within the DIS.

Authors:  Y Guan; K Diallo; M Detorio; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences.

Authors:  Y Guan; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus.

Authors:  Y Guan; J B Whitney; K Diallo; M A Wainberg
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.

Authors:  J L Yovandich; E N Chertova; B P Kane; T D Gagliardi; J W Bess; R C Sowder; L E Henderson; R J Gorelick
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells.

Authors:  M K Hill; M Shehu-Xhilaga; S M Campbell; P Poumbourios; S M Crowe; J Mak
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.

Authors:  F Li; R Goila-Gaur; K Salzwedel; N R Kilgore; M Reddick; C Matallana; A Castillo; D Zoumplis; D E Martin; J M Orenstein; G P Allaway; E O Freed; C T Wild
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

9.  Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals.

Authors:  Nihay Laham-Karam; Eran Bacharach
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

Review 10.  Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

Authors:  Simon Henriet; Gaëlle Mercenne; Serena Bernacchi; Jean-Christophe Paillart; Roland Marquet
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.